Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
Services professionnels
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport What stops CO₂ electroreduction from reaching industrial scale? Explore the key technical and economic barriers blocking cost-effective CO₂RR deployment.
Article | Rapport How do single-point and distributed fiber optic sensing systems differ for structural health monitoring? A technical guide to FBG, Brillouin, and Rayleigh sensing for civil infrastructure.
Article | Rapport How AnaptysBio's rosnilimab targets PD-1-high pathogenic T cells in rheumatoid arthritis — a mechanistically distinct immune tolerizing approach entering Phase III.
Article | Rapport Explore the low-k dielectric materials landscape for 3D IC packaging in 2026: key material classes, IPC codes, assignees, and how to navigate the IP space.
Article | Rapport Nuclear microreactors below 20 MWe are moving from prototype to factory production. Explore the 2026 technology landscape: KRUSTY, Holos-Quad, HALEU fuel, and manufacturing economics.
Article | Rapport A 2026 technology landscape of intestinal organoid disease modeling: key platforms, innovation clusters, application domains, and emerging R&D directions from 80+ records.
Article | Rapport Tarlatamab (Imdelltra) is expanding into limited-stage SCLC and first-line settings. Explore what the DLL3×CD3 BiTE data signals mean for SCLC drug development.
Article | Rapport Explore the key engineering challenges of next-generation electrochromic smart window systems—from ionic transport to large-area coating uniformity—for energy-efficient buildings.
Article | Rapport Explore the 2026 fuel cell bipolar plate materials landscape: graphite composites, metallic plates, coatings, and IP strategy insights from PatSnap Eureka.
Article | Rapport Talquetamab's GPRC5D mechanism, Phase III combination strategies, and competitive positioning against BCMA-targeted bispecific antibodies in relapsed/refractory myeloma.
Article | Rapport Hard vs. soft real-time requirements explained for safety-critical embedded control system design. Understand timing constraints, RTOS scheduling, and IEC 61508.
Article | Rapport Explore the 2026 lithium-sulfur battery materials landscape: cathode host architectures, electrolyte design strategies, and what the patent data reveals.
Article | Rapport A 2026 technology landscape of autonomous vehicle lidar calibration: key patent clusters, assignees, emerging directions, and strategic IP implications across 70+ records.
Article | Rapport How teclistamab (Tecvayli) and talquetamab stack up in later-line myeloma: patent strategy, BCMA vs GPRC5D targeting, and J&J combination data decoded.
Article | Rapport Explore the key engineering barriers to reliable high-cycle fatigue performance in additively manufactured Inconel components — from porosity to residual stress.